G319 Can we predict the severity of coronary artery changes in the BPSU survey of Kawasaki disease from the phenotypic presentation?
BackgroundKawasaki disease (KD) is the commonest cause of paediatric acquired heart disease in the Western world. The Kobayashi score has been shown not to be a reliable indication of disease severity for the UK population and such scoring is needed to predict which children will benefit from adjunc...
Gespeichert in:
Veröffentlicht in: | Archives of disease in childhood 2016-04, Vol.101 (Suppl 1), p.A186-A186 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A186 |
---|---|
container_issue | Suppl 1 |
container_start_page | A186 |
container_title | Archives of disease in childhood |
container_volume | 101 |
creator | Brown, K Tulloh, RMR Ramanan, A Brogan, P Harnden, A Shingadia, D Michie, C Craggs, P Davidson, S Lynn, R Mayon-White, R |
description | BackgroundKawasaki disease (KD) is the commonest cause of paediatric acquired heart disease in the Western world. The Kobayashi score has been shown not to be a reliable indication of disease severity for the UK population and such scoring is needed to predict which children will benefit from adjunct therapy at presentation.MethodsThe recent survey (BPSU) ran from February 2013 to February 2015 covering the UK and Ireland, including questions relating to date of symptom appearance. We determined the link between specific symptoms, in those where the date of appearance of each symptom was recorded and cardiac disease. “Coronary artery abnormality” (CAA) was any abnormality of coronary arteries whereas “Cardiac involvement” also included pericardial effusion, valve regurgitation or myocarditis.Results291 children fulfilled the inclusion criteria for this substudy. CAA rate was 20(±5.5)% for all complete KD (n = 208), but for those with all 5 symptoms at diagnosis, it was just 12.5 (±6.57)%. For those with just 4 symptoms (n = 144), the CAA rate was 23.6(±6.94)%. If the mucositis was absent, CAA rate was 37.5% (n = 8). If mucosa or extremity changes were present (n = 50), there were significantly fewer CAA (12.5% p < 0.05, Chi squared). At diagnosis, if lymphadenopathy, conjunctival involvement or rash were present, then CAA rate was higher (28%). Chi square for trend suggests significantly less cardiac involvement the greater the number of key symptoms present at diagnosis.For incomplete KD (n = 55), the cardiac involvement rate was 5.45(±6.0)%. Atypical KD with CAA (n = 28), was seen predominantly in those |
doi_str_mv | 10.1136/archdischild-2016-310863.310 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1870650384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4316569691</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1294-86a207d4c6811939fc025d55fbf83faa1dc58fbea7e7c816160802e0ea38e3da3</originalsourceid><addsrcrecordid>eNqVkM1OwzAQhC0EEqXwDpbgGrDjxHEkJAQVfwIJJOg52jpr4kLjYKeteuMCD8qTkLQcuHIaafXNzu4QcsTZMedCnoDXVWmDruxbGcWMy0hwpqQ47mSLDHgiVTdOkm0yYIyJKFdK7ZK9EKaM8VgpMSBf14Ln3x-fI6jpEmnjsbS6pW2FNOACvW1X1BmqnXc1-BUF32InuoL6BQO19Rq9eHwa0zD3C1zTd7CEAK-WdschBKTGu9kabCqsXbtqrO6jAtYttNbVZ_tkx8BbwINfHZLx1eXz6Ca6f7i-HZ3fRxMe50mkJMQsKxMtFee5yI1mcVqmqZkYJQwAL3WqzAQhw0wrLrlkisXIEIRCUYIYksPN3sa79zmGtpi6ua-7yIKrjMmUCZV01OmG0t6F4NEUjbez7v2Cs6JvvvjbfNE3X2ya76WzZxv7ZDb9n_MHRIePTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1870650384</pqid></control><display><type>article</type><title>G319 Can we predict the severity of coronary artery changes in the BPSU survey of Kawasaki disease from the phenotypic presentation?</title><source>BMJ Journals - NESLi2</source><creator>Brown, K ; Tulloh, RMR ; Ramanan, A ; Brogan, P ; Harnden, A ; Shingadia, D ; Michie, C ; Craggs, P ; Davidson, S ; Lynn, R ; Mayon-White, R</creator><creatorcontrib>Brown, K ; Tulloh, RMR ; Ramanan, A ; Brogan, P ; Harnden, A ; Shingadia, D ; Michie, C ; Craggs, P ; Davidson, S ; Lynn, R ; Mayon-White, R</creatorcontrib><description>BackgroundKawasaki disease (KD) is the commonest cause of paediatric acquired heart disease in the Western world. The Kobayashi score has been shown not to be a reliable indication of disease severity for the UK population and such scoring is needed to predict which children will benefit from adjunct therapy at presentation.MethodsThe recent survey (BPSU) ran from February 2013 to February 2015 covering the UK and Ireland, including questions relating to date of symptom appearance. We determined the link between specific symptoms, in those where the date of appearance of each symptom was recorded and cardiac disease. “Coronary artery abnormality” (CAA) was any abnormality of coronary arteries whereas “Cardiac involvement” also included pericardial effusion, valve regurgitation or myocarditis.Results291 children fulfilled the inclusion criteria for this substudy. CAA rate was 20(±5.5)% for all complete KD (n = 208), but for those with all 5 symptoms at diagnosis, it was just 12.5 (±6.57)%. For those with just 4 symptoms (n = 144), the CAA rate was 23.6(±6.94)%. If the mucositis was absent, CAA rate was 37.5% (n = 8). If mucosa or extremity changes were present (n = 50), there were significantly fewer CAA (12.5% p < 0.05, Chi squared). At diagnosis, if lymphadenopathy, conjunctival involvement or rash were present, then CAA rate was higher (28%). Chi square for trend suggests significantly less cardiac involvement the greater the number of key symptoms present at diagnosis.For incomplete KD (n = 55), the cardiac involvement rate was 5.45(±6.0)%. Atypical KD with CAA (n = 28), was seen predominantly in those <1 year and 12% had additional cardiac involvement. Most had mucositis if there were no CAA or cardiac involvement. The least likely symptoms were non-purulent conjunctivitis or rash (p < 0.05, chi squared).ConclusionsIn this largest worldwide population series of Kawasaki disease, the rate of cardiac involvement remains extremely high. Those with mucosal involvement are least likely to have cardiac disease. Those without mucosal involvement or extremity changes have a much higher rate of cardiac involvement. This suggests that there may be significant underdiagnosis of Kawasaki disease in the UK, especially if mucosal or extremity changes are not present.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2016-310863.310</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Cardiovascular diseases ; Heart Disorders ; Statistical Analysis ; Symptoms (Individual Disorders)</subject><ispartof>Archives of disease in childhood, 2016-04, Vol.101 (Suppl 1), p.A186-A186</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://adc.bmj.com/content/101/Suppl_1/A186.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://adc.bmj.com/content/101/Suppl_1/A186.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,777,781,3183,23552,27905,27906,77349,77380</link.rule.ids></links><search><creatorcontrib>Brown, K</creatorcontrib><creatorcontrib>Tulloh, RMR</creatorcontrib><creatorcontrib>Ramanan, A</creatorcontrib><creatorcontrib>Brogan, P</creatorcontrib><creatorcontrib>Harnden, A</creatorcontrib><creatorcontrib>Shingadia, D</creatorcontrib><creatorcontrib>Michie, C</creatorcontrib><creatorcontrib>Craggs, P</creatorcontrib><creatorcontrib>Davidson, S</creatorcontrib><creatorcontrib>Lynn, R</creatorcontrib><creatorcontrib>Mayon-White, R</creatorcontrib><title>G319 Can we predict the severity of coronary artery changes in the BPSU survey of Kawasaki disease from the phenotypic presentation?</title><title>Archives of disease in childhood</title><description>BackgroundKawasaki disease (KD) is the commonest cause of paediatric acquired heart disease in the Western world. The Kobayashi score has been shown not to be a reliable indication of disease severity for the UK population and such scoring is needed to predict which children will benefit from adjunct therapy at presentation.MethodsThe recent survey (BPSU) ran from February 2013 to February 2015 covering the UK and Ireland, including questions relating to date of symptom appearance. We determined the link between specific symptoms, in those where the date of appearance of each symptom was recorded and cardiac disease. “Coronary artery abnormality” (CAA) was any abnormality of coronary arteries whereas “Cardiac involvement” also included pericardial effusion, valve regurgitation or myocarditis.Results291 children fulfilled the inclusion criteria for this substudy. CAA rate was 20(±5.5)% for all complete KD (n = 208), but for those with all 5 symptoms at diagnosis, it was just 12.5 (±6.57)%. For those with just 4 symptoms (n = 144), the CAA rate was 23.6(±6.94)%. If the mucositis was absent, CAA rate was 37.5% (n = 8). If mucosa or extremity changes were present (n = 50), there were significantly fewer CAA (12.5% p < 0.05, Chi squared). At diagnosis, if lymphadenopathy, conjunctival involvement or rash were present, then CAA rate was higher (28%). Chi square for trend suggests significantly less cardiac involvement the greater the number of key symptoms present at diagnosis.For incomplete KD (n = 55), the cardiac involvement rate was 5.45(±6.0)%. Atypical KD with CAA (n = 28), was seen predominantly in those <1 year and 12% had additional cardiac involvement. Most had mucositis if there were no CAA or cardiac involvement. The least likely symptoms were non-purulent conjunctivitis or rash (p < 0.05, chi squared).ConclusionsIn this largest worldwide population series of Kawasaki disease, the rate of cardiac involvement remains extremely high. Those with mucosal involvement are least likely to have cardiac disease. Those without mucosal involvement or extremity changes have a much higher rate of cardiac involvement. This suggests that there may be significant underdiagnosis of Kawasaki disease in the UK, especially if mucosal or extremity changes are not present.</description><subject>Cardiovascular diseases</subject><subject>Heart Disorders</subject><subject>Statistical Analysis</subject><subject>Symptoms (Individual Disorders)</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkM1OwzAQhC0EEqXwDpbgGrDjxHEkJAQVfwIJJOg52jpr4kLjYKeteuMCD8qTkLQcuHIaafXNzu4QcsTZMedCnoDXVWmDruxbGcWMy0hwpqQ47mSLDHgiVTdOkm0yYIyJKFdK7ZK9EKaM8VgpMSBf14Ln3x-fI6jpEmnjsbS6pW2FNOACvW1X1BmqnXc1-BUF32InuoL6BQO19Rq9eHwa0zD3C1zTd7CEAK-WdschBKTGu9kabCqsXbtqrO6jAtYttNbVZ_tkx8BbwINfHZLx1eXz6Ca6f7i-HZ3fRxMe50mkJMQsKxMtFee5yI1mcVqmqZkYJQwAL3WqzAQhw0wrLrlkisXIEIRCUYIYksPN3sa79zmGtpi6ua-7yIKrjMmUCZV01OmG0t6F4NEUjbez7v2Cs6JvvvjbfNE3X2ya76WzZxv7ZDb9n_MHRIePTQ</recordid><startdate>201604</startdate><enddate>201604</enddate><creator>Brown, K</creator><creator>Tulloh, RMR</creator><creator>Ramanan, A</creator><creator>Brogan, P</creator><creator>Harnden, A</creator><creator>Shingadia, D</creator><creator>Michie, C</creator><creator>Craggs, P</creator><creator>Davidson, S</creator><creator>Lynn, R</creator><creator>Mayon-White, R</creator><general>BMJ Publishing Group LTD</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201604</creationdate><title>G319 Can we predict the severity of coronary artery changes in the BPSU survey of Kawasaki disease from the phenotypic presentation?</title><author>Brown, K ; Tulloh, RMR ; Ramanan, A ; Brogan, P ; Harnden, A ; Shingadia, D ; Michie, C ; Craggs, P ; Davidson, S ; Lynn, R ; Mayon-White, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1294-86a207d4c6811939fc025d55fbf83faa1dc58fbea7e7c816160802e0ea38e3da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cardiovascular diseases</topic><topic>Heart Disorders</topic><topic>Statistical Analysis</topic><topic>Symptoms (Individual Disorders)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brown, K</creatorcontrib><creatorcontrib>Tulloh, RMR</creatorcontrib><creatorcontrib>Ramanan, A</creatorcontrib><creatorcontrib>Brogan, P</creatorcontrib><creatorcontrib>Harnden, A</creatorcontrib><creatorcontrib>Shingadia, D</creatorcontrib><creatorcontrib>Michie, C</creatorcontrib><creatorcontrib>Craggs, P</creatorcontrib><creatorcontrib>Davidson, S</creatorcontrib><creatorcontrib>Lynn, R</creatorcontrib><creatorcontrib>Mayon-White, R</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database (ProQuest)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brown, K</au><au>Tulloh, RMR</au><au>Ramanan, A</au><au>Brogan, P</au><au>Harnden, A</au><au>Shingadia, D</au><au>Michie, C</au><au>Craggs, P</au><au>Davidson, S</au><au>Lynn, R</au><au>Mayon-White, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>G319 Can we predict the severity of coronary artery changes in the BPSU survey of Kawasaki disease from the phenotypic presentation?</atitle><jtitle>Archives of disease in childhood</jtitle><date>2016-04</date><risdate>2016</risdate><volume>101</volume><issue>Suppl 1</issue><spage>A186</spage><epage>A186</epage><pages>A186-A186</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>BackgroundKawasaki disease (KD) is the commonest cause of paediatric acquired heart disease in the Western world. The Kobayashi score has been shown not to be a reliable indication of disease severity for the UK population and such scoring is needed to predict which children will benefit from adjunct therapy at presentation.MethodsThe recent survey (BPSU) ran from February 2013 to February 2015 covering the UK and Ireland, including questions relating to date of symptom appearance. We determined the link between specific symptoms, in those where the date of appearance of each symptom was recorded and cardiac disease. “Coronary artery abnormality” (CAA) was any abnormality of coronary arteries whereas “Cardiac involvement” also included pericardial effusion, valve regurgitation or myocarditis.Results291 children fulfilled the inclusion criteria for this substudy. CAA rate was 20(±5.5)% for all complete KD (n = 208), but for those with all 5 symptoms at diagnosis, it was just 12.5 (±6.57)%. For those with just 4 symptoms (n = 144), the CAA rate was 23.6(±6.94)%. If the mucositis was absent, CAA rate was 37.5% (n = 8). If mucosa or extremity changes were present (n = 50), there were significantly fewer CAA (12.5% p < 0.05, Chi squared). At diagnosis, if lymphadenopathy, conjunctival involvement or rash were present, then CAA rate was higher (28%). Chi square for trend suggests significantly less cardiac involvement the greater the number of key symptoms present at diagnosis.For incomplete KD (n = 55), the cardiac involvement rate was 5.45(±6.0)%. Atypical KD with CAA (n = 28), was seen predominantly in those <1 year and 12% had additional cardiac involvement. Most had mucositis if there were no CAA or cardiac involvement. The least likely symptoms were non-purulent conjunctivitis or rash (p < 0.05, chi squared).ConclusionsIn this largest worldwide population series of Kawasaki disease, the rate of cardiac involvement remains extremely high. Those with mucosal involvement are least likely to have cardiac disease. Those without mucosal involvement or extremity changes have a much higher rate of cardiac involvement. This suggests that there may be significant underdiagnosis of Kawasaki disease in the UK, especially if mucosal or extremity changes are not present.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/archdischild-2016-310863.310</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9888 |
ispartof | Archives of disease in childhood, 2016-04, Vol.101 (Suppl 1), p.A186-A186 |
issn | 0003-9888 1468-2044 |
language | eng |
recordid | cdi_proquest_journals_1870650384 |
source | BMJ Journals - NESLi2 |
subjects | Cardiovascular diseases Heart Disorders Statistical Analysis Symptoms (Individual Disorders) |
title | G319 Can we predict the severity of coronary artery changes in the BPSU survey of Kawasaki disease from the phenotypic presentation? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A48%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=G319%E2%80%85Can%20we%20predict%20the%20severity%20of%20coronary%20artery%20changes%20in%20the%20BPSU%20survey%20of%20Kawasaki%20disease%20from%20the%20phenotypic%20presentation?&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Brown,%20K&rft.date=2016-04&rft.volume=101&rft.issue=Suppl%201&rft.spage=A186&rft.epage=A186&rft.pages=A186-A186&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/archdischild-2016-310863.310&rft_dat=%3Cproquest_cross%3E4316569691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1870650384&rft_id=info:pmid/&rfr_iscdi=true |